To initiate a Research Proposal or to Ask a Question about studies, please do the following:

  • Login and create an account.
  • Click on the Study ID to view Study Details.
  • If you cannot find the specific study you are looking for, click here to submit an Enquiry
Export to ExcelExport All Studies >
×


1 Result:


Sponsor Study ID ↑ Description Created
 
GSK GSK-CTT116853 A Phase III, 24 Week, Randomized, Double Blind, Double Dummy, Parallel Group Study (with an Extension to 52 Weeks in a Subset of Subjects) Comparing the Efficacy, Safety and Tolerability of the Fixed Dose Triple Combination FF/UMEC/VI Administered Once Daily in the Morning via a Dry Powder Inhaler with Budesonide/Formoterol 400mcg/12mcg Administered Twice-Daily via a Reservoir Inhaler in Subjects with Chronic Obstructive Pulmonary Disease 9/29/2017